Skip to content

Treatment monitoring: no clear benefit to adding viral load to CD4 or clinical symptoms in Thailand and Africa

A lab technician at work in Uganda. Diagnostic equipment in rural health centres is often rudimentary. AMREF is helping to upgrade labs in Kiboga and Luwero districts. Image ©AMREF www.amrefuk.org

Attachment inhibitor BMS-663068 potent and well-tolerated in early study

Safer sex in the treatment era

Choose your runner

Towards a cure for all: How we might do it

Zinc finger gene therapy produces HIV-resistant CD4 T-cells

Zinc-finger nucleases, bound to DNA. Image by Dr Jeff Miller, Sangamo BioSciences, Inc.

Vaginal microbicides may not be safe for rectal use: gels being reformulated

Researcher Peter Anton MD, University of California, Los Angeles

One dose of raltegravir gel three hours after sex might prevent HIV infection